The respective involvement of noradrenaline and its deaminated metabolites in waking and paradoxical sleep: a neuropharmacological model.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D002415:Cats; D002540:Cerebral Cortex / Q000187:drug effects; D003891:Desipramine / Q000494:pharmacology; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004569:Electroencephalography; D004576:Electromyography; D005133:Eye Movements; D005829:Geniculate Bodies / Q000187:drug effects; D006834:Hydrazines / Q000494:pharmacology; D008636:Mesencephalon / Q000378:metabolism*; D008959:Models, Neurological; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism*; D010293:Pargyline / Q000494:pharmacology; D012890:Sleep / Q000187:drug effects; D013681:Tegmentum Mesencephali / Q000187:drug effects / Q000378:metabolism; D014851:Wakefulness / Q000187:drug effects
D006834:Hydrazines; D008996:Monoamine Oxidase Inhibitors; D004295:Dihydroxyphenylalanine; D010293:Pargyline; D003891:Desipramine; D009638:Norepinephrine